In-hospital mortality of hepatorenal syndrome in the United States: Nationwide inpatient sample
Внутрибольничная летальность при гепаторенальном синдроме в США: национальная выборка госпитализаций
2021-12-01
SCID: 54.1/9q7r2cw4
Discuss with AI
National Inpatient Samplehepatorenal syndromein-hospital mortalityliver transplantationmechanical ventilation
Figures from the paper
Abstract (AI)
BACKGROUND: Hepatorenal syndrome (HRS) is a life-threatening condition among patients with advanced liver disease. Data trends specific to hospital mortality and hospital admission resource utilization for HRS remain limited. AIM: To assess the temporal trend in mortality and identify the predictors for mortality among hospital admissions for HRS in the United States. METHODS: We used the National Inpatient Sample database to identify an unweighted sample of 4938 hospital admissions for HRS from 2005 to 2014 (weighted sample of 23973 admissions). The primary outcomes were temporal trends in mortality as well as predictors for hospital mortality. We estimated odds ratios from multi-level mixed effect logistic regression to identify patient characteristics and treatments associated with hospital mortality. RESULTS: < 0.001). On multivariable analysis, older age, alcohol use, coagulopathy, neurological disorder, and need for mechanical ventilation predicted higher hospital mortality, whereas liver transplantation, transjugular intrahepatic portosystemic shunt, and abdominal paracentesis were associated with lower hospital mortality. CONCLUSION: Although there was an increase in resource utilizations, hospital mortality among patients admitted for HRS significantly improved. Several predictors for hospital mortality were identified.
Key Findings
1
Hospital mortality among patients admitted with hepatorenal syndrome significantly improved over time despite increased resource utilization.
2
Liver transplantation, transjugular intrahepatic portosystemic shunt, and abdominal paracentesis were associated with lower hospital mortality.
3
Multilevel mixed-effects logistic regression was used to identify patient characteristics and treatments associated with in-hospital mortality.
4
Older age, alcohol use, coagulopathy, neurological disorders, and mechanical ventilation were associated with higher hospital mortality.
5
The National Inpatient Sample identified 23,973 weighted U.S. hospital admissions for hepatorenal syndrome between 2005 and 2014.
Research Object
Hospital admissions for hepatorenal syndrome in the United States
Research Subject
Temporal trends and predictors of in-hospital mortality, including associated treatments and resource utilization
Publication Details
Publication Date
2021-12-01
Journal
Publisher
ISSN
Cited by
27
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai1
Cited by3
Evaluation of Terlipressin and In-Hospital Mortality in the Treatment of Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI)2026
Trends and Demographics of Hepatorenal Syndrome-Related Mortality in the U.S., 1999–2024: A CDC WONDER Analysis2026
25-Year Mortality Trends of Hepatorenal Syndrome Vs Portal Hypertension in Older U.S. Adults with Liver Diseases: A CDC WONDER and “ARIMA Based” Analysis2026